Apotex Faces Uncertainty After Founder's Mysterious Death


Barry Sherman, who died earlier this month under suspicious circumstances, had set the tone for generic drugmaker's aggressive litigation approach Late Apotex founder and chairman Barry Sherman paid close attention to the generic drugmaker's multiple lawsuits because he viewed them as an essential weapon against larger rivals, say lawyers familiar with his strategy. TORONTO-The path forward for Apotex Inc. is uncertain following the sudden death of founder and chairman Barry Sherman, who was the architect of the generic drugmaker's litigation-heavy strategy.



from Biotech News